✨ Miscellaneous Notices
NEW ZEALAND GAZETTE, No. 8 — 29 JANUARY 2015
a. must state in full the reasons for making the submission; and
b. may state any decision sought on that application; and
c. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
a. where submissions on this application are to be sent; and
b. where requests for copies of the public information relating to the application can be sent; and
c. where public information relating to the application can be viewed; and
d. the director-general’s address for service:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Dermcare-Vet (NZ) Pty. Ltd., Level 8, 53 Fort Street, Auckland. Overseas Address: 7 Centenary Road, Slacks Creek, Queensland 4127, Australia.
Dated at Wellington this 27th day of January 2015.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).
Cancellation of Licence for an Early Childhood Service
Pursuant to Regulation 32(1)(d)(i) of the Education (Early Childhood Services) Regulations 2008, and acting under authority delegated by the Secretary for Education, I hereby cancel the licence dated 11 February 2014, which was granted under those Regulations to Anne-Marie Duff in respect of Portobello/Broadbay Playcentre (81032), situated at Harington Point Road, Portobello.
This notice shall take effect the day after the date of its notification in the New Zealand Gazette.
ANTHONY NEWTON, Senior Manager, ECE Funding and Implementation, Early Learning, Parents and Whānau.
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product:
Combivir
Active Ingredients:
Lamivudine 150mg
Zidovudine 300mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Operations UK Limited (t/a Glaxo Wellcome Operations), Hertfordshire, United Kingdom
GlaxoSmithKline Pharmaceuticals SA, Poznan, Poland
Dated this 22nd day of January 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Next Page →
NZ Gazette 2015, No 8
✨ LLM interpretation of page content
🌾
Notice of Application to Register a Trade Name Product
(continued from previous page)
🌾 Primary Industries & Resources27 January 2015
Trade Name Registration, Agricultural Compounds, Veterinary Medicines, Dermcare Otoflush, Poly(hexamethylene biguanide) hydrochloride, Disodium edetate, Ear flush solution, Dogs
- Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority)
🎓 Cancellation of Licence for an Early Childhood Service
🎓 Education, Culture & ScienceLicence Cancellation, Early Childhood Service, Portobello/Broadbay Playcentre
- Anne-Marie Duff, Licence holder for Portobello/Broadbay Playcentre
- Anthony Newton, Senior Manager, ECE Funding and Implementation, Early Learning, Parents and Whānau
🏥 Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare22 January 2015
Medicine Distribution, Combivir, Lamivudine, Zidovudine, Film coated tablet
- Chris James, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013)